Kolexia
Castelli Joel Oncologie radiothérapie
Castelli Joel
Oncologie radiothérapie
Centre Eugène Marquis
Rennes, France
180 Activités
404 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Tumeurs de la prostate Métastase tumorale Carcinomes Tumeurs de l'oropharynx Récidive tumorale locale Tumeurs du poumon Carcinome épidermoïde Tumeurs du col de l'utérus

Collaborateurs

Voir plus
De Crevoisier Renaud
De Crevoisier Renaud
Centre Eugène Marquis, Rennes, France
Chajon Enrique
Chajon Enrique
Selas Ilc Mallet Proux, Laval, France
Lafond Cedrik
Lafond Cedrik
Gcs Medecine Nucleaire Sarthe_et Siege, Le Mans, France
Gnep Khemara
Gnep Khemara
Gie Groupement D'imagerie Armoricaine, Plérin, France

Industries

Voir plus
Merck-Serono
9 collaboration(s)
Dernière en 2023
ELEKTA SAS
5 collaboration(s)
Dernière en 2020
B3TSI
4 collaboration(s)
Dernière en 2021
BMS
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
The dosimetric parameters impact on local recurrence in stereotactic radiotherapy for brain metastases.
The British journal of radiology   20 février 2024
AIRING: A Phase II Trial Evaluating Conformational Intensity Modulated Radiotherapy With Concomitant Nivolumab Followed by Nivolumab for Patients With Locally Advanced Non-small Cell Lung Cancer
Essai Clinique (BMS)   06 février 2024
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   03 février 2024
Computed tomography synthesis from magnetic resonance imaging using cycle Generative Adversarial Networks with multicenter learning.
Physics and imaging in radiation oncology   17 novembre 2023
O21 104-week efficacy and safety of cipaglucosidase alfa+miglustat in patients with late-onset Pompe disease previously treated with alglucosidase alfa
Neuromuscular disorders : NMD   01 octobre 2023
853O OMITting frontline chemotherapy in head and neck cancer (HNSCC) patients with 1-3 oligometastases using stereotactic ablative radiotherapy (SABR), the GORTEC 2014-04 “OMET” randomized phase II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
P373 Effect size analysis of cipaglucosidase alfa + miglustat versus alglucosidase alfa in ERT-experienced adults with late-onset Pompe disease in PROPEL
Neuromuscular disorders : NMD   01 octobre 2023
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial.
JAMA oncology   18 août 2023
Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer.
Practical radiation oncology   08 juin 2023
CO4.2 - Cost-effectiveness of an adaptive radiotherapy strategy to decrease xerostomia in locally advanced oropharynx carcinoma: An economic evaluation alongside the ARTIX Randomized Clinical Trial matched to the French National Health Insurance Database
EPICLIN 202317e Conférence francophone d’Épidémiologie Clinique30e Journées des statisticiens des Centres de Lutte contre le Cancer   01 mai 2023